Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America
- PMID: 39727661
- PMCID: PMC11726921
- DOI: 10.3390/diseases12120331
Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America
Abstract
Healthy working-age adults are susceptible to illness or caregiving requirements resulting from annual seasonal influenza, leading to considerable societal and economic impacts. The objective of this targeted narrative review is to understand the societal burden of influenza in terms of absenteeism and productivity loss, based on the current literature. This review includes 48 studies on the impact of influenza and influenza-like illness (ILI) and reports on the effect of influenza vaccination, age, disease severity, caring for others, comorbidities, and antiviral prophylaxis on absenteeism and productivity loss due to influenza/ILI, focusing on publications originating from Canada, Europe, and the United States. Influenza/ILI results in substantial work time and productivity loss among working adults and students in Canada, Europe, and the United States, particularly those who are unvaccinated, are <65 years of age, or who have severe disease. Considerable work time and productivity loss is attributable to illness and caregiver burden related to influenza. Further research is required on the impact of influenza on absenteeism and productivity loss in adults with comorbidities to support the development of effective employer policies for working adults with underlying health conditions.
Keywords: absenteeism; caregivers; indirect cost; influenza; influenza-like illness; productivity loss.
Conflict of interest statement
David Fisman has received honoraria for participating in advisory boards with Merck, Sanofi-Pasteur, CSL Seqirus, Pfizer, and AstraZeneca related to influenza, SARS-CoV-2, and pneumococcal vaccines. Myron J. Levin received honoraria from CSL Seqirus, GSK, Pfizer, Moderna, Curevo, AstraZeneca, and Dynavax for taking part in advisory boards. He has also received institution funding for investigator-led studies from GSK. Maarten Postma has received honoraria from CSL Seqirus for taking part in advisory boards. Joaquin Mould-Quevedo is an employee of CSL Seqirus.
Figures
Similar articles
-
Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review.Pharmacoeconomics. 2023 Mar;41(3):253-273. doi: 10.1007/s40273-022-01224-9. Epub 2022 Dec 14. Pharmacoeconomics. 2023. PMID: 36515814 Free PMC article.
-
Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years.Clin Infect Dis. 2009 Feb 1;48(3):292-8. doi: 10.1086/595842. Clin Infect Dis. 2009. PMID: 19115970
-
The impact of influenza on working days lost: a review of the literature.Pharmacoeconomics. 2008;26(11):911-24. doi: 10.2165/00019053-200826110-00004. Pharmacoeconomics. 2008. PMID: 18850761 Review.
-
Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.JAMA. 2000 Oct 4;284(13):1655-63. doi: 10.1001/jama.284.13.1655. JAMA. 2000. PMID: 11015795 Clinical Trial.
-
Health and economic burden of influenza-associated illness in South Africa, 2013-2015.Influenza Other Respir Viruses. 2019 Sep;13(5):484-495. doi: 10.1111/irv.12650. Epub 2019 Jun 11. Influenza Other Respir Viruses. 2019. PMID: 31187609 Free PMC article.
References
-
- European Centre for Disease Prevention and Control . Factsheet About Seasonal Influenza. European Centre for Disease Prevention and Control; Stockholm, Sweden: 2022.
-
- Centers for Disease Control and Prevention . Disease Burden of Flu. Centers for Disease Control and Prevention; Atlanta, GA, USA: 2023.
-
- World Health Organization (WHO) Influenza (Seasonal) [(accessed on 1 October 2023)]. Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources